Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step-up treatment strategies in early rheumatoid arthritis: an indirect comparison of effectiveness and safety of the U-Act-Early and CAMERA-II treat-to-target trials

Maxime M.A. Verhoeven*, Marjolein J.H. De Hair, Janneke Tekstra, Johannes W.J. Bijlsma, Jacob M. Van Laar, Attila Pethoe-Schramm, Michelle E.A. Borm, Evert Jan Ter Borg, Suzanne P. Linn-Rasker, Xavier M. Teitsma, Floris P.J.G. Lafeber, Johannes W.G. Jacobs, Paco M.J. Welsing

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step-up treatment strategies in early rheumatoid arthritis: an indirect comparison of effectiveness and safety of the U-Act-Early and CAMERA-II treat-to-target trials'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Nursing and Health Professions

Medicine and Dentistry